Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Concert Pharmaceutic (NQ: CNCE ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Mar 3, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Concert Pharmaceutic < Previous 1 2 3 4 5 Next > Concert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata February 15, 2023 From Concert Pharmaceuticals, Inc. Via Business Wire CNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders February 13, 2023 From Halper Sadeh LLC Via Business Wire Why Concert Pharmaceuticals Stock Rocketed Higher This Week January 20, 2023 The company is changing hands in a deal worth at least $576 million. Via The Motley Fool CONCERT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Concert Pharmaceuticals, Inc. - CNCE January 20, 2023 From Kahn Swick & Foti, LLC Via Business Wire India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones January 19, 2023 Via Benzinga Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 19, 2023 Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 19, 2023 Via Benzinga Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On Thursday January 19, 2023 U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga Concert Pharmaceuticals's Return On Capital Employed Insights November 29, 2022 Via Benzinga Concert Pharma: Q3 Earnings Insights November 07, 2022 Concert Pharma (NASDAQ:CNCE) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low January 19, 2023 U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday. Via Benzinga CNCE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Concert Pharmaceuticals, Inc. Is Fair to Shareholders January 19, 2023 From Halper Sadeh LLC Via Business Wire Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata January 19, 2023 From Concert Pharmaceuticals Via Business Wire Recap: Concert Pharma Q2 Earnings August 04, 2022 Concert Pharma (NASDAQ:CNCE) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 18, 2023 Via Benzinga Is Ardelyx is A Buy After Slip in Early 2022 November 21, 2022 Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them Via MarketBeat Exposures Product Safety Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research November 21, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Concert Pharmaceuticals to Participate in Fireside Chat at the Jefferies London Healthcare Conference November 09, 2022 From Concert Pharmaceuticals Via Business Wire Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday November 08, 2022 Gainers Via Benzinga Concert Pharmaceuticals Reports Third Quarter 2022 Financial Results November 07, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Concert Pharmaceuticals to Report Third Quarter 2022 Results on November 7, 2022 October 31, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Planet Labs, Core & Main And Some Other Big Stocks Moving Higher On Tuesday September 13, 2022 U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress September 10, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Concert Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference September 06, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Bridges and Landmarks Across the USA Will Illuminate Blue Throughout the Month of September for Alopecia Areata September 01, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 August 25, 2022 Upgrades Via Benzinga Concert Pharmaceuticals Announces That Results From CTP-543 THRIVE‑AA1 Phase 3 Trial in Patients With Alopecia Areata Selected for Late Breaking Presentation at EADV Congress August 22, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Concert Pharmaceuticals Announces Exercise of Warrants Under Existing Financing Arrangement August 22, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Concert Pharmaceuticals Reports Second Quarter 2022 Financial Results August 04, 2022 From Concert Pharmaceuticals, Inc. Via Business Wire Recap Of Monday's Biotech Catalysts - End Of the Day Summary August 01, 2022 Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.